Long‐Term Secondary Preventive Medication Persistence and Adherence in Young Ischemic Stroke Survivors: A Prospective Single‐Center Cohort Study
Brain and Behavior · 2026-02 · 16 (2)
DOI: 10.1002/brb3.71248 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Brain and Behavior, online erschienen am 30.01.2026. Verfasst von Qiqi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical Colleg…. Hauptthemen laut MEDLINE: Secondary Prevention, Ischemic Stroke, Drug Monitoring, Medication Adherence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
The study aimed to evaluate long‐term medication persistence and adherence to secondary prevention therapies in young ischemic stroke survivors (aged 18–49 years) and identify factors influencing these outcomes.
Methods
The single‐center prospective cohort study enrolled young ischemic stroke patients (aged 18–49 years) from March 2017 to March 2023. Medication persistence (continuation of all prescribed secondary prevention drugs) and adherence (assessed by the Morisky Medication Adherence Scale‐8 (MMAS‐8)) were evaluated, with reasons for discontinuation and influencing factors analyzed.
Results
Among 226 patients (median age 35 years, 34.5% female), 80.1% remained persistent with their medication regimen over a median follow‐up of 3.9 years. Patients with persistence had higher rates of large artery atherosclerosis (42% vs. 22.2%, p = 0.015) and comorbid diabetes (13.3% vs. 2.2%, p = 0.015). The median MMAS‐8 score was 7 (6–7.38), with 24.2% showing high adherence, 63% moderate adherence, and 12.8% poor adherence. Poor adherence was associated with younger age (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Lixin Zhou
Förderung
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Wang, Q., Tang, M., Gao, H., Sha, Y., Yao, M., Zhu, Y., Peng, B., Zhou, L., & Ni, J. (2026). Long‐Term Secondary Preventive Medication Persistence and Adherence in Young Ischemic Stroke Survivors: A Prospective Single‐Center Cohort Study. Brain and Behavior, 16(2). https://doi.org/10.1002/brb3.71248
Vancouver
Wang Q, Tang M, Gao H, Sha Y, Yao M, Zhu Y, et al. Long‐Term Secondary Preventive Medication Persistence and Adherence in Young Ischemic Stroke Survivors: A Prospective Single‐Center Cohort Study. Brain and Behavior. 2026;16(2). doi:10.1002/brb3.71248
BibTeX
@article{Wang2026,
author = {Wang, Qiqi and Tang, Mingyu and Gao, Haiquan and Sha, Yuhui and Yao, Ming and Zhu, Yicheng and Peng, Bin and Zhou, Lixin and Ni, Jun},
title = {Long‐Term Secondary Preventive Medication Persistence and Adherence in Young Ischemic Stroke Survivors: A Prospective Single‐Center Cohort Study},
journal = {Brain and Behavior},
year = {2026},
volume = {16},
number = {2},
doi = {10.1002/brb3.71248}
}
EUVIMED